• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在小鼠体内生产人源或人源化抗体。

Production of human or humanized antibodies in mice.

作者信息

Laffleur Brice, Pascal Virginie, Sirac Christophe, Cogné Michel

机构信息

CNRS UMR6101, Contrôle des Réponses Immunes B et Lymphoproliférations, Université de Limoges, Limoges, France.

出版信息

Methods Mol Biol. 2012;901:149-59. doi: 10.1007/978-1-61779-931-0_9.

DOI:10.1007/978-1-61779-931-0_9
PMID:22723099
Abstract

Mice are widely available laboratory animals that can easily be used for the production of antibodies against a broad range of antigens, using well-defined immunization protocols. Such an approach allows optimal in vivo affinity maturation of the humoral response. In addition, high-affinity antibodies arising in this context can readily be further characterized and produced as monoclonals after immortalizing and selecting specific antibody-producing cells through hybridoma derivation. Using such conventional strategies combined with mice that are either genetically engineered to carry humanized immunoglobulin (Ig) genes or engrafted with a human immune system, it is thus easy to obtain and immortalize clones that produce either fully human Ig or antibodies associating variable (V) domains with selected antigen specificities to customized human-like constant regions, with defined effector functions. In some instances, where there is a need for in vivo functional assays of a single antibody with a known specificity, it might be of interest to transiently express that gene in mice by in vivo gene transfer. This approach allows a rapid functional assay. More commonly, mice are used to obtain a diversified repertoire of antibody specificities after immunization by producing antibody molecules in the mouse B cell lineage from mouse strains with transgene Ig genes which are of human, humanized, or chimeric origin. After in vivo maturation of the immune response, this will lead to the secretion of antibodies with optimized antigen binding sites, associated to the desired human constant domains. This chapter focuses on two simple methods: (1) to obtain such humanized Ig mice and (2) to transiently express a human Ig gene in mice using hydrodynamics-based transfection.

摘要

小鼠是广泛可得的实验动物,利用明确的免疫方案,它们可轻松用于制备针对多种抗原的抗体。这种方法能使体液免疫反应在体内实现最佳的亲和力成熟。此外,在此过程中产生的高亲和力抗体,在通过杂交瘤衍生使特定抗体产生细胞永生化并进行筛选后,可很容易地进一步鉴定并制备成单克隆抗体。将这些传统策略与经过基因工程改造以携带人源化免疫球蛋白(Ig)基因或移植了人类免疫系统的小鼠相结合,就很容易获得并使产生完全人源Ig或具有将可变(V)结构域与选定抗原特异性关联到定制的类人恒定区且具有明确效应功能的抗体的克隆永生化。在某些情况下,若需要对具有已知特异性的单一抗体进行体内功能测定,通过体内基因转移在小鼠中瞬时表达该基因可能会很有意义。这种方法能实现快速的功能测定。更常见的是,通过在具有人源、人源化或嵌合来源的转基因Ig基因的小鼠品系的B细胞谱系中产生抗体分子,小鼠在免疫后可获得多样化的抗体特异性库。免疫反应在体内成熟后,这将导致分泌具有优化抗原结合位点且与所需人恒定结构域相关的抗体。本章重点介绍两种简单方法:(1)获得此类人源化Ig小鼠,(2)利用基于流体动力学的转染在小鼠中瞬时表达人Ig基因。

相似文献

1
Production of human or humanized antibodies in mice.在小鼠体内生产人源或人源化抗体。
Methods Mol Biol. 2012;901:149-59. doi: 10.1007/978-1-61779-931-0_9.
2
Rearrangement of only one human IGHV gene is sufficient to generate a wide repertoire of antigen specific antibody responses in transgenic mice.仅重排一个人类IGHV基因就足以在转基因小鼠中产生广泛的抗原特异性抗体应答。
Mol Immunol. 2006 Apr;43(11):1827-35. doi: 10.1016/j.molimm.2005.10.015. Epub 2005 Dec 15.
3
The diversity of antigen-specific monoclonal antibodies from transgenic mice bearing human immunoglobulin gene miniloci.携带人免疫球蛋白基因小基因座的转基因小鼠产生的抗原特异性单克隆抗体的多样性。
Eur J Immunol. 1994 Nov;24(11):2672-81. doi: 10.1002/eji.1830241116.
4
Antigen-specific human monoclonal antibodies from transgenic mice.来自转基因小鼠的抗原特异性人单克隆抗体。
Methods Mol Biol. 2014;1060:245-76. doi: 10.1007/978-1-62703-586-6_13.
5
Cloning of the genes for T84.66, an antibody that has a high specificity and affinity for carcinoembryonic antigen, and expression of chimeric human/mouse T84.66 genes in myeloma and Chinese hamster ovary cells.对癌胚抗原有高特异性和亲和力的抗体T84.66的基因克隆,以及人/鼠嵌合T84.66基因在骨髓瘤细胞和中国仓鼠卵巢细胞中的表达。
Cancer Res. 1990 Apr 1;50(7):2128-34.
6
Human antibody production in transgenic animals.转基因动物中的人抗体生产。
Arch Immunol Ther Exp (Warsz). 2015 Apr;63(2):101-8. doi: 10.1007/s00005-014-0322-x. Epub 2014 Dec 3.
7
Cloning and high level expression of a chimeric antibody with specificity for human carcinoembryonic antigen.一种对人癌胚抗原有特异性的嵌合抗体的克隆与高效表达。
J Immunol. 1988 Dec 1;141(11):4053-60.
8
Humanization of a highly stable single-chain antibody by structure-based antigen-binding site grafting.通过基于结构的抗原结合位点嫁接实现高稳定性单链抗体的人源化
Mol Immunol. 2008 May;45(9):2474-85. doi: 10.1016/j.molimm.2008.01.016. Epub 2008 Mar 3.
9
[Transgenesis and humanization of murine antibodies].[鼠源抗体的转基因与人性化改造]
Med Sci (Paris). 2009 Dec;25(12):1149-54. doi: 10.1051/medsci/200925121149.
10
Antigen-specific human monoclonal antibodies from mice engineered with human Ig heavy and light chain YACs.利用人Ig重链和轻链酵母人工染色体构建的小鼠产生的抗原特异性人单克隆抗体。
Nat Genet. 1994 May;7(1):13-21. doi: 10.1038/ng0594-13.

引用本文的文献

1
Monoclonal Antibody Generation Using Single B Cell Screening for Treating Infectious Diseases.利用单 B 细胞筛选技术生成单克隆抗体以治疗传染病。
BioDrugs. 2024 Jul;38(4):477-486. doi: 10.1007/s40259-024-00667-0. Epub 2024 Jul 2.
2
Application of recombinant antibodies for treatment of infection: Current status and future perspective.重组抗体在 感染治疗中的应用:现状与展望。
Front Immunol. 2022 Aug 23;13:972930. doi: 10.3389/fimmu.2022.972930. eCollection 2022.
3
Development of CAR T Cell Therapy in Children-A Comprehensive Overview.
儿童嵌合抗原受体T细胞疗法的发展——全面概述
J Clin Med. 2022 Apr 12;11(8):2158. doi: 10.3390/jcm11082158.
4
High-Throughput Monoclonal Antibody Discovery from Phage Libraries: Challenging the Current Preclinical Pipeline to Keep the Pace with the Increasing mAb Demand.从噬菌体文库中进行高通量单克隆抗体发现:挑战当前临床前流程以跟上单克隆抗体需求的增长步伐。
Cancers (Basel). 2022 Mar 4;14(5):1325. doi: 10.3390/cancers14051325.
5
Retrospective analysis of the preparation and application of immunotherapy in cancer treatment (Review).癌症治疗中免疫疗法的制备与应用的回顾性分析(综述)。
Int J Oncol. 2022 Feb;60(2). doi: 10.3892/ijo.2022.5302. Epub 2022 Jan 4.
6
Effective high-throughput isolation of fully human antibodies targeting infectious pathogens.高效高通量分离针对传染性病原体的全人源抗体。
Nat Protoc. 2021 Jul;16(7):3639-3671. doi: 10.1038/s41596-021-00554-w. Epub 2021 May 25.
7
Chimeric antigen receptor preparation from hybridoma to T-cell expression.从杂交瘤到T细胞表达的嵌合抗原受体制备
Antib Ther. 2019 May 31;2(2):56-63. doi: 10.1093/abt/tbz007. eCollection 2019 Apr.
8
Identifying the Epitope Regions of Therapeutic Antibodies Based on Structure Descriptors.基于结构描述符鉴定治疗性抗体的表位区域。
Int J Mol Sci. 2017 Nov 24;18(12):2457. doi: 10.3390/ijms18122457.
9
Beyond humanization and de-immunization: tolerization as a method for reducing the immunogenicity of biologics.超越人源化和去免疫原性:耐受化为降低生物制剂免疫原性的方法。
Expert Rev Clin Pharmacol. 2013 Nov;6(6):651-62. doi: 10.1586/17512433.2013.835698.